What does the DTS (Decision Tree Study) study recommend?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duke Treadmill Score (DTS) Study: A Prognostic Tool for Cardiovascular Risk Assessment

The Duke Treadmill Score (DTS) is an excellent prognostic tool in symptomatic women, with a low DTS being associated with an annual mortality rate of ≈0.25% in contrast to an annual mortality rate of ≈5% in those with a high-risk DTS, with lower mortality rates among women than men. 1

What is the Duke Treadmill Score?

The DTS is a validated risk stratification tool that integrates multiple parameters from an exercise treadmill test (ETT) to improve diagnostic and prognostic accuracy. The formula is:

DTS = Exercise time − (5 × ST-segment deviation) − (4 × angina score index)

Where:

  • Exercise time is measured in minutes on the standard Bruce protocol
  • ST-segment deviation is the greatest net ST-segment deviation in any lead (except aVR)
  • Angina score index: 0 = no angina, 1 = non-limiting angina, 2 = exercise-limiting angina

Risk Stratification Categories

The DTS categorizes patients into three risk groups:

  • Low risk: DTS ≥5
  • Moderate risk: DTS -10 to 4
  • High risk: DTS ≤-11

Clinical Significance and Recommendations

Diagnostic Value

  • In symptomatic women referred for ETT followed by coronary angiography, significant coronary stenosis (≥75%) was present in:
    • 19% of low-risk women
    • 35% of moderate-risk women
    • 89% of high-risk women 1

Prognostic Value

  • Low DTS: Associated with an annual mortality rate of approximately 0.25%
  • High-risk DTS: Associated with an annual mortality rate of approximately 5% 1
  • The DTS is a valuable tool for predicting the risk of future myocardial infarction

Management Algorithm Based on DTS

  1. Low-risk DTS (≥5):

    • Low annual mortality rate (≈0.25%)
    • Generally can be managed conservatively
  2. Moderate-risk DTS (-10 to 4):

    • Should be referred for additional risk stratification with stress imaging study 1
    • Consider further evaluation with stress echocardiography or myocardial perfusion imaging
  3. High-risk DTS (≤-11):

    • High annual mortality rate (≈5%)
    • Consider direct referral for coronary angiography

Gender Differences

  • The DTS has diagnostic and prognostic value in both women and men 1
  • Women generally have lower mortality rates than men within the same DTS category
  • The DTS may be less effective at predicting prognosis in elderly women (aged ≥75 years) 1

Important Considerations

  • The quoted mortality rates are derived from earlier patient cohorts; contemporary cohorts would likely have lower high-risk mortality rates 1
  • Exercise capacity (measured in METs or time) is one of the strongest predictors of outcomes for women 1
  • Women who achieve <5 METs are at increased risk of death and related IHD events, independent of traditional cardiac risk factors 1

Limitations and Pitfalls

  • Exertional chest pain symptoms were less accurate for detection of obstructive coronary artery disease in women 1
  • The DTS should be interpreted alongside other important prognostic variables from the ETT, including:
    • Exercise capacity
    • Chronotropic response
    • Heart rate recovery
    • Blood pressure response 1

Conclusion

The DTS provides valuable risk stratification that goes beyond the ST-segment response alone. It should be calculated and reported for all exercise treadmill tests to guide clinical decision-making regarding the need for additional testing or interventions based on cardiovascular risk.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.